Table 1.

Peptides used in preclinical and clinical studies and their source proteins

SequenceProtein from which peptide sequence is derived
Group IKIMDQVQQA (P1)Adenomatous polyposis coli (APC)
RLQEDPPAGV (P2)Ubiquitin conjugating enzyme E2, HHR6A
KLDVGNAEV (P3)BAP31 or CDM protein, 6c6-AG
YLMDTSGKV (P6)Replication protein A
ILDDIGHGV (P7)Abl-binding protein 3c
LLDRFLATV (P8)Cyclin I
Group IIFLYDDNQRV (P4)Topoisomerase IIα; topoisomerase IIβ
ALMEQQHYV (P5)Integrin β 8 subunit precursor
LLIDDKGTIKL (P9)Cell division control protein 2 (CDC2)
YLIELIDRV (P13)TACE, ADAM17
NLMEQPIKV (P14)Junction plakoglobin, g-catenin
FLAEDALNTV(P15)EDDR1, RTK 6, H-RYK